Cargando…

Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial

Detalles Bibliográficos
Autores principales:	Sekandarzad, Asieb, Weber, Enya, Prager, Eric Peter, Graf, Erika, Bettinger, Dominik, Wengenmayer, Tobias, Supady, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013157/ https://www.ncbi.nlm.nih.gov/pubmed/35428345 http://dx.doi.org/10.1186/s13063-022-06267-z

Ejemplares similares

Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
por: Sekandarzad, Asieb, et al.
Publicado: (2022)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
por: Supady, Alexander, et al.
Publicado: (2021)

Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study
por: Luxenburger, Hendrik, et al.
Publicado: (2022)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
por: Rieder, Marina, et al.
Publicado: (2020)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial
por: Rieder, Marina, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply
por: Supady, Alexander
Publicado: (2021)

Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study
por: Hunyady, Peter, et al.
Publicado: (2022)

Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
por: Supady, Alexander, et al.
Publicado: (2020)

Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2021)

Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2022)

On the Use of Hemadsorption with CytoSorb in Patients with Septic Shock. Comment on Kogelmann et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J. Clin. Med. 2021, 10, 2939
por: Supady, Alexander, et al.
Publicado: (2022)

Hospital networks and patient transport capacity during the COVID-19 pandemic when intensive care resources become scarce
por: Supady, Alexander, et al.
Publicado: (2021)

Choosing the right reference cohort for assessing outcome of venovenous ECMO
por: Supady, Alexander, et al.
Publicado: (2022)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

Mobile ECMO retrieval of patients during the COVID‐19 pandemic
por: Widmeier, Eugen, et al.
Publicado: (2021)

Levosimendan in acute heart failure with severely reduced kidney function, a propensity score matched registry study
por: Rottmann, Felix Arne, et al.
Publicado: (2022)

THE DURATION OF MECHANICAL VENTILATION PRIOR TO VV-ECMO IN PATIENTS WITH COVID-19 DOES NOT HAVE AN IMPACT ON SURVIVAL DURING THREE WAVES OF THE PANDEMIC
por: WIDMEIER, E., et al.
Publicado: (2022)

Controlled automated reperfusion of the whole body after 120 minutes of Cardiopulmonary resuscitation: first clinical report
por: Trummer, Georg, et al.
Publicado: (2017)

Extracorporeal membrane oxygenation during the first three waves of the coronavirus disease 2019 pandemic—A retrospective single‐center registry study
por: Widmeier, Eugen, et al.
Publicado: (2022)

A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
por: Rilinger, Jonathan, et al.
Publicado: (2020)

Survival outcomes and mobilization during venovenous extracorporeal membrane oxygenation: a retrospective cohort study
por: Rottmann, Felix A., et al.
Publicado: (2023)

Vector Selection of a Quadripolar Left Ventricular Pacing Lead Affects Acute Hemodynamic Response to Cardiac Resynchronization Therapy: A Randomized Cross-Over Trial
por: Asbach, Stefan, et al.
Publicado: (2013)

Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
por: Matsumura, Tsuyoshi, et al.
Publicado: (2022)

Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study
por: Enya, Kazuaki, et al.
Publicado: (2018)

Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation
por: Bemtgen, Xavier, et al.
Publicado: (2021)

Myocarditis mortality with and without COVID-19: insights from a national registry
por: Bemtgen, Xavier, et al.
Publicado: (2022)

Effect of Facial Cosmetic Acupuncture on Facial Elasticity: An Open-Label, Single-Arm Pilot Study
por: Yun, Younghee, et al.
Publicado: (2013)

Bone-level implants placed in the anterior maxilla: an open-label, single-arm observational study
por: Gao, EnFeng, et al.
Publicado: (2017)

Integrated cognitive behavioral therapy for chronic pain: An open-labeled prospective single-arm trial
por: Taguchi, Kayoko, et al.
Publicado: (2021)

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
por: Boye, Kjetil, et al.
Publicado: (2021)

Effects of Bilwa-Lajadi syrup in emesis gravidarum – an exploratory single arm open labeled trial
por: Singh, Deepika, et al.
Publicado: (2022)

Welcome with Open arms!
por: Simonds, Anita K.
Publicado: (2015)

Cytokine adsorption in severe, refractory septic shock
por: Wendel Garcia, Pedro David, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19
por: Rybalko, Andrey, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19
por: Nardelli, Pasquale, et al.
Publicado: (2021)

Effect of a Mindfulness-Based Intervention for Chronic Migraine and High Frequency Episodic Migraine in Adolescents: A Pilot Single-Arm Open-Label Study
por: Grazzi, Licia, et al.
Publicado: (2021)

An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery—the BUMPER study
por: Amaral, Teresa, et al.
Publicado: (2020)

Multi-Watt Near-Infrared Phototherapy for the Treatment of Comorbid Depression: An Open-Label Single-Arm Study
por: Henderson, Theodore A., et al.
Publicado: (2017)

Single-arm open-label study of Durolane (NASHA nonanimal hyaluronic acid) for the treatment of osteoarthritis of the thumb
por: Velasco, Eloisa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bscrrsihpg8vbl9smcidu9ro15